SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Vanteck (vrb-cdnx, vttcf)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: gg cox who wrote (273)3/23/2006 10:54:20 PM
From: thaidiamond  Read Replies (2) of 413
 
A U.S. listing meant has typically meant taking on regulatory burdens more onerous than those in Canada, particularly since the passage of the U.S. Sarbanes-Oxley legislation.

And it much more expensive - particularly for a start-up junior.One junior explorer was considering getting an AMEX (American Stock and Options Exchange) listing, but hesitated because of the extra cost and regulatory burden. Their director and officer insurance would go from about C$40,000 to C$250,000 overnight.

To gain an AMEX listing, a company must satisfy one of a number of initial listing criteria such as, if stockholders’ equity is below US$4 million, you must have a market cap of US$75 million or have total assets and total revenue of $75 million in the last fiscal year (or two of the three last fiscal years).

Such requirements put an AMEX listing out of reach for many juniors, and, of course, the requirements to list on the NYSE are even more stringent.

Hence the Pink Sheets - which is a private corporation - as at least the initial US presence for many Canadian start-ups.

The benefits and the results achieved by companies that have migrated to the U.S. market are hard to argue with. Having access to a market roughly 10 times the size and all the accompanying capital usually brings in an increase liquidity to the stock.

My source for this info is here: financialsense.com.

I believe VRB will go this route - eventually. The benefits are just too compelling and should we continue to see "orders of consequence", US institutional players need such a listing to invest.

But I also feel that management is still focused - rightly IMHO - on making VRB a "going concern." Until that's fully achieve, they'll probably need to keep their capital on getting their manufacturing capacity fully on line
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News